肥胖管理市場分析及預測（至2035年）：依類型、產品、服務、技術、組件、應用、最終用戶、設備、解決方案分類

預計到2034年，全球肥胖管理市場規模將從2024年的25億美元成長至40億美元，年複合成長率約為5.3%。該市場涵蓋旨在預防、診斷和治療肥胖的各種服務和產品，包括藥物、外科手術、營養補充劑和生活方式干涉。全球肥胖率的上升推動了對結合醫療、營養和行為方法的創新體重管理解決方案的需求。市場成長的促進因素包括公眾意識的提高、醫療技術的進步以及政府的支持，這些因素共同促進了個人化治療方案和技術主導型介入措施的發展。

肥胖管理市場正經歷強勁成長，這主要得益於人們對有效體重管理方案日益成長的認知和需求。在該市場中，藥物治療細分市場成長最為顯著，這主要得益於針對肥胖症的先進藥物的研發。減重手術緊隨其後，體現了其在顯著減輕體重和改善健康方面的有效性。行為療法細分市場也呈現成長勢頭，強調生活方式調整和心理支持的重要性。數位健康平台和穿戴式裝置等創新技術增強了患者的參與度和監測能力，從而促進了市場擴張。代餐產品和營養補充品為體重管理提供了便利且個人化的解決方案，因此越來越受歡迎。遠端醫療服務的整合進一步便利了肥胖管理計畫的普及，尤其是在偏遠地區。這些因素的匯聚凸顯了肥胖管理的綜合性方法，並為這個充滿活力的市場中的相關人員提供了豐厚的機會。

肥胖管理市場以產品組合多元化為特徵，尤其重視創新解決方案。隨著企業尋求透過價值主導提案來獲取市場佔有率，定價策略的競爭日益激烈。近期推出的產品反映出市場正朝著整合式健康管理解決方案的方向發展，並專注於個人化、全面性的方法。這種動態的市場格局凸顯了適應性和創新性在維持競爭優勢的重要性。競爭基準分析顯示，市場由少數幾家主要企業主導，這些企業不斷透過策略聯盟和收購來強化產品系列。監管影響至關重要，嚴格的指導方針影響產品開發和打入市場策略。在監管核准和消費者對非侵入性治療方案偏好的推動下，對非侵入性治療方法的需求正在激增。大量新型療法的開發平臺以及對生活方式干涉項目的日益重視表明，該市場具有持續成長的潛力。

主要趨勢和促進因素：

受全球肥胖盛行率上升和健康意識增強的推動，肥胖管理市場正經歷蓬勃發展。關鍵趨勢包括數位健康技術的融合，例如行動應用程式和穿戴式設備，這些技術能夠提供個人化的體重管理解決方案。這些技術使個人能夠監測自身進展並做出明智的生活方式選擇，從而提高患者的參與度。製藥業的進步也發揮關鍵作用，新型抗肥胖藥物不斷湧入市場。這些藥物為那些努力減重的人帶來了新的希望，並且與生活方式的改變相結合，能夠提供有效的治療方案。此外，人們越來越關注減重手術作為治療重度肥胖的有效手段，這也促進了市場的擴張。公共和私營部門對綜合性肥胖預防項目的投資進一步推動了市場成長。在醫療基礎設施正在發展的未來地區，隨著宣傳宣傳活動的開展，新的機會正在湧現。專注於創新且經濟高效的解決方案的公司將佔據新興市場的優勢地位。技術、醫學和公共衛生措施的整合預計將推動肥胖管理市場的發展，並加速應對這一重大的全球健康挑戰。

目錄

第1章執行摘要

第2章 市場亮點

第3章 市場動態

• 宏觀經濟分析
• 市場趨勢
• 市場促進因素
• 市場機遇
• 市場限制
• 複合年均成長率：成長分析
• 影響分析
• 新興市場
• 技術藍圖
• 戰略框架

第4章 細分市場分析

• 市場規模及預測：依類型
  • 藥物治療
  • 外科器械
  • 非侵入式設備
  • 營養補充品
  • 行為療法
• 市場規模及預測：依產品分類
  • 處方藥
  • 非處方藥
  • 食慾抑制劑
  • 脂肪吸收抑制劑
  • 代謝加速器
• 市場規模及預測：依服務分類
  • 減重計畫
  • 諮詢服務
  • 營養服務
  • 健身計劃
  • 減重手術
• 市場規模及預測：依技術分類
  • 穿戴式裝置
  • 行動應用
  • 遠端醫療
  • 人工智慧
  • 虛擬實境
• 市場規模及預測：依組件分類
  • 軟體
  • 硬體
  • 服務
• 市場規模及預測：依應用領域分類
  • 醫院用途
  • 居家照護
  • 診所
  • 健身中心
  • 研究所
• 市場規模及預測：依最終用戶分類
  • 成人
  • 兒童
  • 老年人
  • 運動員
  • 企業員工
• 市場規模及預測：依設備分類
  • 胃束帶
  • 胃內球囊
  • 電刺激設備
  • 胃內球囊
• 市場規模及預測：按解決方案分類
  • 綜合體重管理
  • 生活方式改善
  • 手術介入
  • 藥物治療

第5章 區域分析

• 北美洲
  • 美國
  • 加拿大
  • 墨西哥
• 拉丁美洲
  • 巴西
  • 阿根廷
  • 其他拉丁美洲地區
• 亞太地區
  • 中國
  • 印度
  • 韓國
  • 日本
  • 澳洲
  • 台灣
  • 亞太其他地區
• 歐洲
  • 德國
  • 法國
  • 英國
  • 西班牙
  • 義大利
  • 其他歐洲地區
• 中東和非洲
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非
  • 撒哈拉以南非洲
  • 其他中東和非洲地區

第6章 市場策略

• 需求與供給差距分析
• 貿易和物流限制
• 價格、成本和利潤率趨勢
• 市場滲透率
• 消費者分析
• 法規概述

第7章 競爭訊息

• 市場定位
• 市場占有率
• 競爭基準
• 主要企業的策略

第8章 公司簡介

• Novo Nordisk
• Eisai
• Arena Pharmaceuticals
• Orexigen Therapeutics
• Vivus
• Zafgen
• Rhythm Pharmaceuticals
• Soleno Therapeutics
• 9 Meters Biopharma
• Altimmune
• Gelesis
• Sorrento Therapeutics
• Astra Zeneca
• Pfizer
• Boehringer Ingelheim
• Amgen
• Alnylam Pharmaceuticals
• Bristol Myers Squibb
• Takeda Pharmaceutical
• Lilly

第9章：關於我們

Obesity Management Market is anticipated to expand from $2.5 billion in 2024 to $4.0 billion by 2034, growing at a CAGR of approximately 5.3%. The Obesity Management Market encompasses a range of services and products aimed at preventing, diagnosing, and treating obesity. This includes pharmaceuticals, surgical procedures, dietary supplements, and lifestyle interventions. With rising global obesity rates, there is a growing demand for innovative solutions that combine medical, nutritional, and behavioral approaches to manage weight effectively. The market is driven by increasing awareness, healthcare advancements, and supportive government initiatives, fostering opportunities for growth and development in personalized treatment plans and technology-driven interventions.

The Obesity Management Market is experiencing robust growth, fueled by increasing awareness and demand for effective weight management solutions. Within this market, the pharmacotherapy segment stands out as the top-performing sub-segment, driven by the development of advanced medications targeting obesity. Bariatric surgery follows closely, reflecting its effectiveness in achieving significant weight loss and health improvements. The behavioral therapy sub-segment is also gaining momentum, emphasizing the importance of lifestyle changes and psychological support. Innovative technologies, such as digital health platforms and wearable devices, are enhancing patient engagement and monitoring, contributing to the market's expansion. Meal replacement products and dietary supplements are witnessing increased adoption, offering convenient and personalized solutions for weight management. The integration of telehealth services is further facilitating access to obesity management programs, particularly in remote areas. The convergence of these elements underscores a comprehensive approach to obesity management, presenting lucrative opportunities for stakeholders in this dynamic market.

The Obesity Management Market is characterized by a diverse array of product offerings, with a notable emphasis on innovative solutions. Pricing strategies are becoming increasingly competitive, as companies strive to capture market share through value-driven propositions. Recent product launches have focused on personalized and holistic approaches, reflecting a shift towards integrated health management solutions. This dynamic landscape underscores the importance of adaptability and innovation in maintaining a competitive edge. In terms of competition benchmarking, the market is dominated by a few key players, who are continually enhancing their product portfolios through strategic alliances and acquisitions. Regulatory influences play a pivotal role, with stringent guidelines shaping product development and market entry strategies. The market is witnessing a surge in demand for non-invasive treatments, driven by regulatory approvals and consumer preference for less intrusive options. The robust pipeline of novel therapeutics and the growing emphasis on lifestyle intervention programs highlight the market's potential for sustained growth.

Geographical Overview:

The obesity management market is witnessing notable growth across various regions, each presenting unique opportunities. North America dominates the market, driven by high obesity rates and increasing public awareness. Government initiatives and healthcare policies support the adoption of obesity management solutions, further propelling the market. Europe follows, with rising health consciousness and robust healthcare infrastructure enhancing market prospects. The region's focus on preventive healthcare and wellness programs contributes to its growth. In the Asia Pacific, the market is expanding rapidly due to urbanization, lifestyle changes, and increasing disposable incomes. Emerging economies like China and India are investing heavily in healthcare, creating lucrative opportunities. Latin America and the Middle East & Africa are emerging markets with significant potential. In Latin America, rising obesity rates and growing healthcare investments are driving demand. Meanwhile, the Middle East & Africa are focusing on improving healthcare access and infrastructure, recognizing the importance of obesity management in public health.

The global obesity management market is increasingly influenced by tariffs, geopolitical tensions, and evolving supply chain dynamics, particularly in Japan, South Korea, China, and Taiwan. Japan and South Korea are investing in local production capabilities to mitigate tariff impacts and ensure supply chain resilience. China is focusing on self-reliance, driven by trade tensions and a robust domestic market demand. Taiwan remains pivotal in medical technology manufacturing but is vulnerable to geopolitical risks. The parent market is experiencing steady growth, driven by rising obesity rates and a shift towards holistic health solutions. By 2035, market evolution will hinge on innovation, strategic alliances, and supply chain agility. Middle East conflicts could exacerbate energy costs, affecting production and distribution logistics globally.

Key Trends and Drivers:

The obesity management market is experiencing dynamic growth, driven by rising obesity prevalence and increasing health awareness globally. Key trends include the integration of digital health technologies, such as mobile apps and wearable devices, which facilitate personalized weight management solutions. These technologies empower individuals to monitor their progress and make informed lifestyle choices, thereby enhancing patient engagement. Pharmaceutical advancements are also playing a pivotal role, with novel anti-obesity drugs entering the market. These medications offer new hope for individuals struggling with weight loss, providing effective options when combined with lifestyle changes. Furthermore, the growing emphasis on bariatric surgeries as a viable intervention for severe obesity is contributing to market expansion. Public and private sectors are investing in comprehensive obesity prevention programs, further driving market growth. Opportunities exist in developing regions where healthcare infrastructure is improving, and awareness campaigns are gaining traction. Companies focusing on innovative, cost-effective solutions are well-positioned to capture emerging markets. The convergence of technology, pharmaceuticals, and public health initiatives is set to propel the obesity management market forward, addressing a critical global health challenge.

Research Scope:

• Estimates and forecasts the overall market size across type, application, and region.
• Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
• Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
• Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
• Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
• Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
• Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

• 1.1 Market Size and Forecast
• 1.2 Market Overview
• 1.3 Market Snapshot
• 1.4 Regional Snapshot
• 1.5 Strategic Recommendations
• 1.6 Analyst Notes

2 Market Highlights

• 2.1 Key Market Highlights by Type
• 2.2 Key Market Highlights by Product
• 2.3 Key Market Highlights by Services
• 2.4 Key Market Highlights by Technology
• 2.5 Key Market Highlights by Component
• 2.6 Key Market Highlights by Application
• 2.7 Key Market Highlights by End User
• 2.8 Key Market Highlights by Device
• 2.9 Key Market Highlights by Solutions

3 Market Dynamics

• 3.1 Macroeconomic Analysis
• 3.2 Market Trends
• 3.3 Market Drivers
• 3.4 Market Opportunities
• 3.5 Market Restraints
• 3.6 CAGR Growth Analysis
• 3.7 Impact Analysis
• 3.8 Emerging Markets
• 3.9 Technology Roadmap
• 3.10 Strategic Frameworks
  • 3.10.1 PORTER's 5 Forces Model
  • 3.10.2 ANSOFF Matrix
  • 3.10.3 4P's Model
  • 3.10.4 PESTEL Analysis

4 Segment Analysis

• 4.1 Market Size & Forecast by Type (2020-2035)
  • 4.1.1 Pharmacotherapy
  • 4.1.2 Surgical Devices
  • 4.1.3 Non-Invasive Devices
  • 4.1.4 Dietary Supplements
  • 4.1.5 Behavioral Therapy
• 4.2 Market Size & Forecast by Product (2020-2035)
  • 4.2.1 Prescription Drugs
  • 4.2.2 Over-the-Counter Drugs
  • 4.2.3 Appetite Suppressants
  • 4.2.4 Fat Absorption Inhibitors
  • 4.2.5 Metabolism Boosters
• 4.3 Market Size & Forecast by Services (2020-2035)
  • 4.3.1 Weight Loss Programs
  • 4.3.2 Counseling Services
  • 4.3.3 Nutritional Services
  • 4.3.4 Fitness Programs
  • 4.3.5 Bariatric Surgery
• 4.4 Market Size & Forecast by Technology (2020-2035)
  • 4.4.1 Wearable Devices
  • 4.4.2 Mobile Applications
  • 4.4.3 Telemedicine
  • 4.4.4 Artificial Intelligence
  • 4.4.5 Virtual Reality
• 4.5 Market Size & Forecast by Component (2020-2035)
  • 4.5.1 Software
  • 4.5.2 Hardware
  • 4.5.3 Services
• 4.6 Market Size & Forecast by Application (2020-2035)
  • 4.6.1 Hospital Use
  • 4.6.2 Home Care
  • 4.6.3 Clinics
  • 4.6.4 Fitness Centers
  • 4.6.5 Research Institutes
• 4.7 Market Size & Forecast by End User (2020-2035)
  • 4.7.1 Adults
  • 4.7.2 Pediatrics
  • 4.7.3 Geriatrics
  • 4.7.4 Athletes
  • 4.7.5 Corporate Employees
• 4.8 Market Size & Forecast by Device (2020-2035)
  • 4.8.1 Gastric Bands
  • 4.8.2 Gastric Balloons
  • 4.8.3 Electrical Stimulation Devices
  • 4.8.4 Intragastric Balloons
• 4.9 Market Size & Forecast by Solutions (2020-2035)
  • 4.9.1 Comprehensive Weight Management
  • 4.9.2 Lifestyle Modification
  • 4.9.3 Surgical Intervention
  • 4.9.4 Pharmacological Treatment

5 Regional Analysis

• 5.1 Global Market Overview
• 5.2 North America Market Size (2020-2035)
  • 5.2.1 United States
    • 5.2.1.1 Type
    • 5.2.1.2 Product
    • 5.2.1.3 Services
    • 5.2.1.4 Technology
    • 5.2.1.5 Component
    • 5.2.1.6 Application
    • 5.2.1.7 End User
    • 5.2.1.8 Device
    • 5.2.1.9 Solutions
  • 5.2.2 Canada
    • 5.2.2.1 Type
    • 5.2.2.2 Product
    • 5.2.2.3 Services
    • 5.2.2.4 Technology
    • 5.2.2.5 Component
    • 5.2.2.6 Application
    • 5.2.2.7 End User
    • 5.2.2.8 Device
    • 5.2.2.9 Solutions
  • 5.2.3 Mexico
    • 5.2.3.1 Type
    • 5.2.3.2 Product
    • 5.2.3.3 Services
    • 5.2.3.4 Technology
    • 5.2.3.5 Component
    • 5.2.3.6 Application
    • 5.2.3.7 End User
    • 5.2.3.8 Device
    • 5.2.3.9 Solutions
• 5.3 Latin America Market Size (2020-2035)
  • 5.3.1 Brazil
    • 5.3.1.1 Type
    • 5.3.1.2 Product
    • 5.3.1.3 Services
    • 5.3.1.4 Technology
    • 5.3.1.5 Component
    • 5.3.1.6 Application
    • 5.3.1.7 End User
    • 5.3.1.8 Device
    • 5.3.1.9 Solutions
  • 5.3.2 Argentina
    • 5.3.2.1 Type
    • 5.3.2.2 Product
    • 5.3.2.3 Services
    • 5.3.2.4 Technology
    • 5.3.2.5 Component
    • 5.3.2.6 Application
    • 5.3.2.7 End User
    • 5.3.2.8 Device
    • 5.3.2.9 Solutions
  • 5.3.3 Rest of Latin America
    • 5.3.3.1 Type
    • 5.3.3.2 Product
    • 5.3.3.3 Services
    • 5.3.3.4 Technology
    • 5.3.3.5 Component
    • 5.3.3.6 Application
    • 5.3.3.7 End User
    • 5.3.3.8 Device
    • 5.3.3.9 Solutions
• 5.4 Asia-Pacific Market Size (2020-2035)
  • 5.4.1 China
    • 5.4.1.1 Type
    • 5.4.1.2 Product
    • 5.4.1.3 Services
    • 5.4.1.4 Technology
    • 5.4.1.5 Component
    • 5.4.1.6 Application
    • 5.4.1.7 End User
    • 5.4.1.8 Device
    • 5.4.1.9 Solutions
  • 5.4.2 India
    • 5.4.2.1 Type
    • 5.4.2.2 Product
    • 5.4.2.3 Services
    • 5.4.2.4 Technology
    • 5.4.2.5 Component
    • 5.4.2.6 Application
    • 5.4.2.7 End User
    • 5.4.2.8 Device
    • 5.4.2.9 Solutions
  • 5.4.3 South Korea
    • 5.4.3.1 Type
    • 5.4.3.2 Product
    • 5.4.3.3 Services
    • 5.4.3.4 Technology
    • 5.4.3.5 Component
    • 5.4.3.6 Application
    • 5.4.3.7 End User
    • 5.4.3.8 Device
    • 5.4.3.9 Solutions
  • 5.4.4 Japan
    • 5.4.4.1 Type
    • 5.4.4.2 Product
    • 5.4.4.3 Services
    • 5.4.4.4 Technology
    • 5.4.4.5 Component
    • 5.4.4.6 Application
    • 5.4.4.7 End User
    • 5.4.4.8 Device
    • 5.4.4.9 Solutions
  • 5.4.5 Australia
    • 5.4.5.1 Type
    • 5.4.5.2 Product
    • 5.4.5.3 Services
    • 5.4.5.4 Technology
    • 5.4.5.5 Component
    • 5.4.5.6 Application
    • 5.4.5.7 End User
    • 5.4.5.8 Device
    • 5.4.5.9 Solutions
  • 5.4.6 Taiwan
    • 5.4.6.1 Type
    • 5.4.6.2 Product
    • 5.4.6.3 Services
    • 5.4.6.4 Technology
    • 5.4.6.5 Component
    • 5.4.6.6 Application
    • 5.4.6.7 End User
    • 5.4.6.8 Device
    • 5.4.6.9 Solutions
  • 5.4.7 Rest of APAC
    • 5.4.7.1 Type
    • 5.4.7.2 Product
    • 5.4.7.3 Services
    • 5.4.7.4 Technology
    • 5.4.7.5 Component
    • 5.4.7.6 Application
    • 5.4.7.7 End User
    • 5.4.7.8 Device
    • 5.4.7.9 Solutions
• 5.5 Europe Market Size (2020-2035)
  • 5.5.1 Germany
    • 5.5.1.1 Type
    • 5.5.1.2 Product
    • 5.5.1.3 Services
    • 5.5.1.4 Technology
    • 5.5.1.5 Component
    • 5.5.1.6 Application
    • 5.5.1.7 End User
    • 5.5.1.8 Device
    • 5.5.1.9 Solutions
  • 5.5.2 France
    • 5.5.2.1 Type
    • 5.5.2.2 Product
    • 5.5.2.3 Services
    • 5.5.2.4 Technology
    • 5.5.2.5 Component
    • 5.5.2.6 Application
    • 5.5.2.7 End User
    • 5.5.2.8 Device
    • 5.5.2.9 Solutions
  • 5.5.3 United Kingdom
    • 5.5.3.1 Type
    • 5.5.3.2 Product
    • 5.5.3.3 Services
    • 5.5.3.4 Technology
    • 5.5.3.5 Component
    • 5.5.3.6 Application
    • 5.5.3.7 End User
    • 5.5.3.8 Device
    • 5.5.3.9 Solutions
  • 5.5.4 Spain
    • 5.5.4.1 Type
    • 5.5.4.2 Product
    • 5.5.4.3 Services
    • 5.5.4.4 Technology
    • 5.5.4.5 Component
    • 5.5.4.6 Application
    • 5.5.4.7 End User
    • 5.5.4.8 Device
    • 5.5.4.9 Solutions
  • 5.5.5 Italy
    • 5.5.5.1 Type
    • 5.5.5.2 Product
    • 5.5.5.3 Services
    • 5.5.5.4 Technology
    • 5.5.5.5 Component
    • 5.5.5.6 Application
    • 5.5.5.7 End User
    • 5.5.5.8 Device
    • 5.5.5.9 Solutions
  • 5.5.6 Rest of Europe
    • 5.5.6.1 Type
    • 5.5.6.2 Product
    • 5.5.6.3 Services
    • 5.5.6.4 Technology
    • 5.5.6.5 Component
    • 5.5.6.6 Application
    • 5.5.6.7 End User
    • 5.5.6.8 Device
    • 5.5.6.9 Solutions
• 5.6 Middle East & Africa Market Size (2020-2035)
  • 5.6.1 Saudi Arabia
    • 5.6.1.1 Type
    • 5.6.1.2 Product
    • 5.6.1.3 Services
    • 5.6.1.4 Technology
    • 5.6.1.5 Component
    • 5.6.1.6 Application
    • 5.6.1.7 End User
    • 5.6.1.8 Device
    • 5.6.1.9 Solutions
  • 5.6.2 United Arab Emirates
    • 5.6.2.1 Type
    • 5.6.2.2 Product
    • 5.6.2.3 Services
    • 5.6.2.4 Technology
    • 5.6.2.5 Component
    • 5.6.2.6 Application
    • 5.6.2.7 End User
    • 5.6.2.8 Device
    • 5.6.2.9 Solutions
  • 5.6.3 South Africa
    • 5.6.3.1 Type
    • 5.6.3.2 Product
    • 5.6.3.3 Services
    • 5.6.3.4 Technology
    • 5.6.3.5 Component
    • 5.6.3.6 Application
    • 5.6.3.7 End User
    • 5.6.3.8 Device
    • 5.6.3.9 Solutions
  • 5.6.4 Sub-Saharan Africa
    • 5.6.4.1 Type
    • 5.6.4.2 Product
    • 5.6.4.3 Services
    • 5.6.4.4 Technology
    • 5.6.4.5 Component
    • 5.6.4.6 Application
    • 5.6.4.7 End User
    • 5.6.4.8 Device
    • 5.6.4.9 Solutions
  • 5.6.5 Rest of MEA
    • 5.6.5.1 Type
    • 5.6.5.2 Product
    • 5.6.5.3 Services
    • 5.6.5.4 Technology
    • 5.6.5.5 Component
    • 5.6.5.6 Application
    • 5.6.5.7 End User
    • 5.6.5.8 Device
    • 5.6.5.9 Solutions

6 Market Strategy

• 6.1 Demand-Supply Gap Analysis
• 6.2 Trade & Logistics Constraints
• 6.3 Price-Cost-Margin Trends
• 6.4 Market Penetration
• 6.5 Consumer Analysis
• 6.6 Regulatory Snapshot

7 Competitive Intelligence

• 7.1 Market Positioning
• 7.2 Market Share
• 7.3 Competition Benchmarking
• 7.4 Top Company Strategies

8 Company Profiles

• 8.1 Novo Nordisk
  • 8.1.1 Overview
  • 8.1.2 Product Summary
  • 8.1.3 Financial Performance
  • 8.1.4 SWOT Analysis
• 8.2 Eisai
  • 8.2.1 Overview
  • 8.2.2 Product Summary
  • 8.2.3 Financial Performance
  • 8.2.4 SWOT Analysis
• 8.3 Arena Pharmaceuticals
  • 8.3.1 Overview
  • 8.3.2 Product Summary
  • 8.3.3 Financial Performance
  • 8.3.4 SWOT Analysis
• 8.4 Orexigen Therapeutics
  • 8.4.1 Overview
  • 8.4.2 Product Summary
  • 8.4.3 Financial Performance
  • 8.4.4 SWOT Analysis
• 8.5 Vivus
  • 8.5.1 Overview
  • 8.5.2 Product Summary
  • 8.5.3 Financial Performance
  • 8.5.4 SWOT Analysis
• 8.6 Zafgen
  • 8.6.1 Overview
  • 8.6.2 Product Summary
  • 8.6.3 Financial Performance
  • 8.6.4 SWOT Analysis
• 8.7 Rhythm Pharmaceuticals
  • 8.7.1 Overview
  • 8.7.2 Product Summary
  • 8.7.3 Financial Performance
  • 8.7.4 SWOT Analysis
• 8.8 Soleno Therapeutics
  • 8.8.1 Overview
  • 8.8.2 Product Summary
  • 8.8.3 Financial Performance
  • 8.8.4 SWOT Analysis
• 8.9 9 Meters Biopharma
  • 8.9.1 Overview
  • 8.9.2 Product Summary
  • 8.9.3 Financial Performance
  • 8.9.4 SWOT Analysis
• 8.10 Altimmune
  • 8.10.1 Overview
  • 8.10.2 Product Summary
  • 8.10.3 Financial Performance
  • 8.10.4 SWOT Analysis
• 8.11 Gelesis
  • 8.11.1 Overview
  • 8.11.2 Product Summary
  • 8.11.3 Financial Performance
  • 8.11.4 SWOT Analysis
• 8.12 Sorrento Therapeutics
  • 8.12.1 Overview
  • 8.12.2 Product Summary
  • 8.12.3 Financial Performance
  • 8.12.4 SWOT Analysis
• 8.13 Astra Zeneca
  • 8.13.1 Overview
  • 8.13.2 Product Summary
  • 8.13.3 Financial Performance
  • 8.13.4 SWOT Analysis
• 8.14 Pfizer
  • 8.14.1 Overview
  • 8.14.2 Product Summary
  • 8.14.3 Financial Performance
  • 8.14.4 SWOT Analysis
• 8.15 Boehringer Ingelheim
  • 8.15.1 Overview
  • 8.15.2 Product Summary
  • 8.15.3 Financial Performance
  • 8.15.4 SWOT Analysis
• 8.16 Amgen
  • 8.16.1 Overview
  • 8.16.2 Product Summary
  • 8.16.3 Financial Performance
  • 8.16.4 SWOT Analysis
• 8.17 Alnylam Pharmaceuticals
  • 8.17.1 Overview
  • 8.17.2 Product Summary
  • 8.17.3 Financial Performance
  • 8.17.4 SWOT Analysis
• 8.18 Bristol Myers Squibb
  • 8.18.1 Overview
  • 8.18.2 Product Summary
  • 8.18.3 Financial Performance
  • 8.18.4 SWOT Analysis
• 8.19 Takeda Pharmaceutical
  • 8.19.1 Overview
  • 8.19.2 Product Summary
  • 8.19.3 Financial Performance
  • 8.19.4 SWOT Analysis
• 8.20 Lilly
  • 8.20.1 Overview
  • 8.20.2 Product Summary
  • 8.20.3 Financial Performance
  • 8.20.4 SWOT Analysis

9 About Us

• 9.1 About Us
• 9.2 Research Methodology
• 9.3 Research Workflow
• 9.4 Consulting Services
• 9.5 Our Clients
• 9.6 Client Testimonials
• 9.7 Contact Us